ASHPOfficial

Transitions of care prioritizes coordinating, integrating, and continuing care to improve patient outcomes and reduce unnecessary readmissions. Pharmacists play a significant role in this process through each level of acuity. In this episode, we discuss key elements of transitions of care from the ICU and medicine floors to the outpatient settings, navigating medication reconciliations and varying types of health systems. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Sodium Glucose Cotransporter-2 Inhibitors (SGLT2) have demonstrated improvement in patient outcomes across several disease states including patients with type 2 diabetes, heart failure and chronic kidney disease.  Despite guideline recommendations for the use of these agents in each of these disease states, utilization of SGLT2 remains relatively low. This podcast discusses some of the barriers to utilization of SGLT2 and strategies to increase uptake of this therapy among patients with diabetes, heart failure and chronic kidney disease.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

If you didn’t make it to the 2024 Midyear Clinical Meeting & Exhibition or didn’t catch all of the emergency medicine related content, we have you covered!  Presenters will give pearl-style recaps of their talks and provide additional insight into application and implementation into practice.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Navigating a pharmacy residency can be overwhelming, but resilience and support can make all the difference. Hear from Brody Maack and Jerica Lam as they reflect on the challenges they've faced, how they’ve prioritized wellness, and the lessons they’ve learned along the way. Whether you’re starting residency or supporting someone who is, this episode offers valuable insights and encouragement.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership episode, Alfred Awuah, chair of the New Practitioners Forum (NPF) Executive Committee, sits down with the 2024 NPF Distinguished Service Awardee, Charnae Ross, to discuss what membership within the forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader. 

This podcast will empower new pharmacists to transform innovative ideas into impactful evidence. From developing research questions to navigating the peer-review process, this team will break down the steps to conducting meaningful studies and successfully sharing your findings. Join us as we uncover tips, tools, and expert insights to elevate pharmacy practice through research.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Kevin M. Zinchuk, PharmD, CCRP, Denise Scarpelli, PharmD, MBA, and Jill Blind, PharmD, CCRP, give you a sneak peek into the upcoming Advanced Therapeutics Summit at the 2025 Pharmacy Futures Meeting. Tune in as we highlight key topics—from patient access and financial impact to operational strategies and interdepartmental collaboration—that will equip pharmacy leaders with practical tools to navigate this evolving landscape. Don’t miss this preview of one of the most anticipated events of the conference!

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide information about how preceptors can maximize remote learning opportunities. The speakers will provide practical advice on how to engage and motivate learners along with addressing challenges that occur with remote learning.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Indrani Kar, manager, formulary and drug policy at University Hospitals as she shares what drew her to a career in pharmacy, her experiences behind the scenes in a health-system setting, and the interdisciplinary team she works with to shape drug policy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide members with an analysis of the Trump Administration’s Executive Order (EO) on drug pricing. We’ll talk through what the EO means for the 340B program, the Inflation Reduction Act’s negotiated drug pricing program, and site neutral payment, and what ASHP will be watching in the coming weeks. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.